Foundation welcomes the addition of lupus to NHF subsidy list
The Lupus Foundation of Jamaica (LFJ) board and its members have welcomed Tuesday’s announcement by Prime Minister Andrew Holness that lupus is to be included as one of the chronic conditions attracting a subsidy from the National Health Fund (NHF).
“LFJ has provided its members with access to pharmacy discounts, support-group meetings, and health professionals for over 30 years, in addition to our ongoing efforts to increase public awareness of the disease. We applaud this measure as an act of compassion and an indication of greater awareness of lupus, its prevalence in Jamaica, and the ongoing expenses incurred by affected persons,” said Dr Desiree Tulloch-Reid, president of the LFJ.
Lupus is a chronic or lifelong illness caused by a dysfunction of the immune system and can be very expensive to treat. The LFJ is hoping that all drugs used to treat lupus, including mycophenylate mofetil, will be on the NHF subsidy list.
Jamaica is considered to have a high prevalence of the disease, with an estimated 6,000 persons affected. Lupus most commonly has its onset among young women, but individuals of any gender or age can be affected.
One of its major activities is patient support and counselling. The foundation encourages research in areas of diagnosis and treatment of lupus. Visit lupusfoundationjamaica.org for more information and to get involved.
For more information about this topic, contact Tulloch-Reid at 1-876-574-4954 or email@example.com.